Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03127215
Title Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603)
Acronym NCT-PMO-1603
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Center for Tumor Diseases, Heidelberg
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Medizinische Fakultät der TU Dresden Dresden 01307 Germany Details
Universitätsklinikum Essen Essen 45147 Germany Details
Universitätsklinikum Frankfurt Frankfurt 60590 Germany Details
Universitätsklinikum Freiburg Freiburg 79106 Germany Details
National Center for Tumordiseases (NCT) Heidelberg 69120 Germany Details
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz Mainz 55131 Germany Details
Klinikum der Universität München-Großhadern München 81377 Germany Details
Klinik Schillerhöhe Stuttgart 70376 Germany Details
Universitätsklinikum Tübingen Tuebingen 72076 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field